Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$871,873,528
+$28,186,293 QoQ
Shares Held
6,785,008
-3.3% QoQ
Ownership
0.275%
of shares outstanding
% of Portfolio
1.97%
of 13F equity value
Holder Rank
#42
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $3,887,775,493 across 10 Drug Manufacturers - General names. MRK ranks #3 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,110,133 | $1,805,760,478 | |
| 2 | LLY |
ELI LILLY & Co
|
743,966 | $892,335,213 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
6,785,008 | $871,873,528 | |
| 4 | GSK |
GSK plc
|
3,599,521 | $188,686,890 | |
| 5 | PFE |
Pfizer Inc
|
2,179,317 | $52,477,953 | |
| 6 | NVS |
Novartis AG
|
245,957 | $38,546,381 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
411,483 | $23,709,650 | |
| 8 | SNY |
Sanofi
|
285,165 | $12,165,138 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $871,873,528 | 6,785,008 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $843,687,235 | 7,013,777 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $723,151,462 | 6,870,145 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $556,065,625 | 6,625,350 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $512,131,398 | 6,469,573 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $600,188,856 | 6,686,596 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $613,321,159 | 6,165,271 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $671,371,716 | 5,912,044 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $659,642,549 | 5,328,292 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $623,735,303 | 4,727,058 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $438,899,039 | 4,025,858 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $414,776,902 | 4,028,916 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $417,462,903 | 3,617,843 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $324,866,865 | 3,053,547 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $348,694,880 | 3,142,811 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $267,545,128 | 3,106,655 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $283,534,597 | 3,109,955 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $315,671,211 | 3,847,303 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $290,264,343 | 3,787,374 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $278,674,023 | 3,710,212 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $277,784,952 | 3,571,878 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $252,907,988 | 3,280,683 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $247,577,404 | 3,026,620 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $250,066,494 | 3,014,664 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $228,866,276 | 2,959,604 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $234,443,930 | 3,047,102 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||